QCG
AMRX icon

Quadrant Capital Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Quadrant Capital Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$634 Buy
+51
New +$685 ﹤0.01% 2621
2023
Q2 		– Sell
-328
Closed -$456 – 2686
2023
Q1 		$456 Sell
328
-2,144
-87% -$4.27K ﹤0.01% 2615
2022
Q4 		$4.92K Buy
2,472
+1,726
+231% +$3.87K ﹤0.01% 2200
2022
Q3 		$2K Buy
+746
New +$2.09K ﹤0.01% 2326
2019
Q3 		– Sell
-119
Closed – – 2287
2019
Q2 		$0 Hold
119
– – ﹤0.01% 2310
2019
Q1 		$1K Sell
119
-24
-17% -$317 ﹤0.01% 2127
2018
Q4 		$1K Sell
143
-46
-24% -$829 ﹤0.01% 2012
2018
Q3 		$3K Hold
189
– – ﹤0.01% 1686
2018
Q2 		$2K Buy
+189
New +$3.32K ﹤0.01% 1829

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return